Therefore, the aim of the analysis performed in the study was to assess the expression of IL-21 and IL-22 in the tumor tissue and the concentration of these parameters in the serum and peritoneal fluid in patients with ovarian serous cancer, taking into account the degrees of histological differentiation of the tumor. The gene discussed is IL22; the disease is neoplasm.